Scientific Board
The Science Doesn't Bend.
Neither Do They.
The clinicians and researchers who set, review, and validate every standard OLMA VITAE accredits against.
Board Members
Governance by practicing clinicians
-
Manuel Ravier
Head of Department, MRD Ltd
Manuel Ravier Head of Department, MRD LtdDegree: MD, PhD in Clinical Medicine Specialises: Metabolic health & diagnostics Experience: 18 years -
Timothée Moiroux
Researcher, OLMA VITAE
Timothée Moiroux Researcher, OLMA VITAEDegree: PhD in Bio Science Specialises: Ageing biology & longevity Experience: 10 years -
Mark Rubio
Board Member, MedMit Ltd
Mark Rubio Board Member, MedMit LtdDegree: MSc in Health Informatics Specialises: Clinical data standards Experience: 14 years -
Yezmi Dazzel
Board Member, ABC Tech
Yezmi Dazzel Board Member, ABC TechDegree: PhD in Biomedical Engineering Specialises: Diagnostic imaging & AI Experience: 12 years -
Alessandra Conti
Board Member, Liguria Health
Alessandra Conti Board Member, Liguria HealthDegree: MD, Specialist in Endocrinology Specialises: Preventive & hormonal medicine Experience: 21 years -
Johan Verhoeven
Board Member, Delft BioSystems
Johan Verhoeven Board Member, Delft BioSystemsDegree: PhD in Molecular Biology Specialises: Cellular regeneration Experience: 16 years
Governance & Independence
A board that answers to evidence, not institutions.
The Board operates independently of any single accredited institution, with a published conflict-of-interest policy and fixed review cadence.
- No Board member holds a financial interest in an accredited institution
- Protocol reviews follow a fixed quarterly cycle
- Conflicts of interest are declared and published per protocol
- Board composition is reviewed annually by OLMA governance
-
EVIDENCE-BASED PROTOCOLS
Documented and Peer Reviewed.
Every protocol is grounded in peer-reviewed research and clinical evidence, ensuring recommendations are based on established science.
-
INTERNATIONAL STANDARDS
Aligned with Global Standards.
Our framework aligns with recognised standards, including ISO, WHO, and ICH-GCP, ensuring consistent and accountable practices.
HOW IT WORKS
How a protocol becomes a standard
A rigorous four-stage process designed to turn emerging evidence into trusted, clinically validated protocols.
-
Protocol Draft
Board members draft a candidate protocol from current evidence.
-
Peer Review
Independent clinical review of the supporting evidence base.
-
Outcome Testing
Validated against real patient outcome data.
-
Publication
Added to the shared protocol library for accredited partners.
RESEARCH COLLABORATIONS
Working with institutions, not around them.
ACADEMIC PARTNERSHIPS
Grounded in ongoing academic exchange.
OLMA VITAE maintains formal ties with academic institutions to keep protocols current with published research.
BECOME A PARTNER
Shape the future of longevity medicine, together
Partner with OLMA VITAE to advance scientific excellence and establish trusted global standards.